In the meta-analysis of three microarray datasets, we have different cell lines of the same cancer type with distinct platforms. In your idea is it logical to compare deferentially expressed genes in these derivatives of a cancer?

This support site is intended to help people with technical questions about Bioconductor packages, not general statistical/analysis questions. You might consider asking on Biostars.